Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/175264
Title: | Clinical, pathological and PAM50 gene expression features of HER2-low breast cancer |
Author: | Prat Aparicio, Aleix Schettini, Francesco Chic Ruché, Núria Brasó Maristany, Fara Paré, Laia Pascual, Tomás Conte, Benedetta Martínez Sáez, Olga Adamo, Barbara Vidal Losada, Maria Jesús Fernández Martínez, Aranzazu González Farré, Blanca Sanfeliu, Esther Cejalvo Andújar, Juan Miguel Perrone, Giuseppe Sabarese, Giovanna Zalfa, Francesca Villagrasa, Patricia Gavilá, Joaquín Barrios, Carlos H. Lluch, Ana Martín, Miguel Placido, Sabino De Barnadas, Esther Locci, Mariavittoria Peg, Vicente Fasan, Roberta |
Keywords: | Càncer de mama Expressió gènica Breast cancer Gene expression |
Issue Date: | 4-Jan-2021 |
Publisher: | Springer Nature |
Abstract: | Novel antibody-drug conjugates against HER2 are showing high activity in HER2-negative breast cancer (BC) with low HER2 expression (i.e., 1+ or 2+ and lack of ERBB2 amplification). However, the clinical and molecular features of HER2-low BC are yet to be elucidated. Here, we collected retrospective clinicopathological and PAM50 data from 3,689 patients with HER2-negative disease and made the following observations. First, the proportion of HER2-low was higher in HR-positive disease (65.4%) than triple-negative BC (TNBC, 36.6%). Second, within HR-positive disease, ERBB2 and luminal-related genes were more expressed in HER2-low than HER2 0. In contrast, no gene was found differentially expressed in TNBC according to HER2 expression. Third, within HER2-low, ERBB2 levels were higher in HR-positive disease than TNBC. Fourth, HER2-low was not associated with overall survival in HR-positive disease and TNBC. Finally, the reproducibility of HER2-low among pathologists was suboptimal. This study emphasizes the large biological heterogeneity of HER2-low BC, and the need to implement reproducible and sensitive assays to measure low HER2 expression. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41523-020-00208-2 |
It is part of: | Npj Breast Cancer, 2021, vol. 7 |
URI: | http://hdl.handle.net/2445/175264 |
Related resource: | https://doi.org/10.1038/s41523-020-00208-2 |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
706374.pdf | 1.69 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License